NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. 

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

  • Outbrain Inc. (NASDAQ: OB) Click to Learn More

Outbrain Inc. has agreed to merge with Teads. As part of the proposed transaction, Outbrain will issue 35 million shares of its common stock.

  • Aerovate Therapeutics, Inc. (NASDAQ: AVTE) Click to Learn More

Aerovate Therapeutics, Inc. has agreed to a merger with Jade Biosciences. At the close of the proposed transaction, Aerovate stockholders are anticipated to own approximately 1.6% of the combined company.

  • Barnes Group, Inc. (NYSE: B) Click to Learn More

Barnes Group, Inc. has entered into a definitive agreement with funds managed by affiliates of Apollo Global Management, Inc for $47.50 per share in cash.

  • Manitex International, Inc. (NASDAQ: MNTX) Click to Learn More

Manitex International Inc. is set to merge with Tadano Ltd. for $5.80 per share in cash.

Why Your Participation Matters:

SHAREHOLDER CASES: ADDRESSING THE INJUSTICE

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact the Firm at moon@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Moon K. Young
Chief of Operations
Kuehn Law, PLLC
53 Hill Street, Suite 605
Southampton, NY 11968
moon@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-ob-avte-b-and-mntx-investors-to-contact-law-firm-302294069.html

SOURCE Kuehn Law, PLLC

Copyright 2024 PR Newswire

Aerovate Therapeutics (NASDAQ:AVTE)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Aerovate Therapeutics 차트를 더 보려면 여기를 클릭.
Aerovate Therapeutics (NASDAQ:AVTE)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Aerovate Therapeutics 차트를 더 보려면 여기를 클릭.